Johnson & Johnson

NYSE:JNJ   11:25:02 AM EDT
163.35
-0.01 (-0.01%)
Officer Changes, Mergers / Acquisitions

Johnson & Johnson Announces Plans To Accelerate Innovation, Serve Patients And Consumers, Unlock Value Through Intent To Separate Consumer Health Business

Published: 11/12/2021 11:48 GMT
Johnson & Johnson (JNJ) - Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value Through Intent to Separate Consumer Health Business.
J&j - New Consumer Health Company Expected to Complete Separation in 18 to 24 Months.
J&j - Intent to Separate Consumer Health Business.
J&j - Joaquin Duato Would Continue to Lead New Johnson & Johnson Following Completion of Planned Separation.
J&j - Planned New Consumer Health Company Employees Are Expected to Continue Participating in Their Current Johnson & Johnson Pay.
J&j - Transaction is Intended to Qualify As a Tax-free Separation for U.S. Federal Income Tax Purposes.
J&j - Board of Directors' Intent is to Effect Planned Separation Through Capital Markets, Creating Two Independent, Market-leading Companies.
J&j - Expected That Overall Shareholder Dividend Will Remain at Least at Same Level Following Completion of Transaction.
J&j - Targeting Completion of Planned Separation in 18 to 24 Months.
J&j - New Consumer Health Company's Board and Leadership Would Be Determined and Announced in Due Course As Planned Separation Process Progresses.
J&j - Alex Gorsky Will Serve As Executive Chairman of Johnson & Johnson and Transition Chief Executive Officer Role to Mr. Joaquin Duato.
J&j - New Consumer Health Segment is Expected to Generate Revenue of Approximately $15 Billion in Full-year 2021.